Renal cell carcinoma clinical trials

Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)

This study helps cancer researchers agree on how to measure important treatment effects like how long people live or how long their cancer stays stable. It aims to make sure everyone uses the same rules, so we can better compare different cancer treatments and improve care.